Czop J K, Austen K F
Proc Natl Acad Sci U S A. 1985 May;82(9):2751-5. doi: 10.1073/pnas.82.9.2751.
Human monocytes possess a receptor for ingestion of particulate activators of the human alternative complement pathway that functions in the absence of plasma proteins and is distinct from the receptors for Fc-IgG and the major cleavage fragment of the third component of complement (C3b). Incubation of monolayers of monocytes with 1.1 X 10(6) to 2.2 X 10(7) glucan particles per ml initiated a phagocytic response comparable to that obtained with zymosan particles, of which beta-glucan is a constituent along with mannan. Maximal quantities of 4.93 +/- 3.43 ng of leukotriene B4 (LTB4) and 0.43 +/- 0.23 ng of leukotriene C4 (LTC4) (mean +/- SD, n = 3) were released by 10(6) monocytes stimulated with 1.1 X 10(7) glucan particles per ml. Preincubation of monocytes with 50 micrograms of soluble beta-glucan per ml reduced subsequent monocyte ingestion of 5 X 10(6) zymosan particles per ml and 2.2 X 10(6) glucan particles per ml by 52% and 55%, respectively, and diminished release of LTB4 by monocytes stimulated with 2 X 10(8) zymosan particles per ml and 8.6 X 10(6) glucan particles per ml by 73% and 61%, respectively. Preincubation with 1 mg of soluble mannan per ml had little effect on monocyte phagocytosis or LTB4 generation in response to either zymosan or glucan particles, and neither soluble beta-glucan nor mannan stimulated generation of LTB4 or LTC4. The effect of pretreatment of monocytes with soluble beta-glucan was time dependent, with the maximal effect being evident within 20 min of pretreatment, and was specific for zymosan or glucan particles in that the LTB4 and LTC4 release induced by 2.5 microM calcium ionophore A23187 was unaffected. That both phagocytosis and leukotriene generation are inhibited by soluble beta-glucan but not by mannan at a rate compatible with the phagocytic process of monocyte monolayers indicates ligand specificity for a beta-glucan receptor. As the beta-glucan receptor recognizes particulate activators of the alternative complement pathway, the nonimmune response to a single stimulus induces complement activation, phagocytosis, and leukotriene generation.
人类单核细胞拥有一种受体,用于摄取人类替代补体途径的颗粒状激活剂,该受体在无血浆蛋白的情况下发挥作用,且与Fc-IgG受体和补体第三成分(C3b)的主要裂解片段受体不同。每毫升含1.1×10⁶至2.2×10⁷个葡聚糖颗粒的单核细胞单层培养物与酵母聚糖颗粒(其中β-葡聚糖与甘露聚糖是其成分)孵育,引发的吞噬反应相当。每毫升含1.1×10⁷个葡聚糖颗粒刺激10⁶个单核细胞,可释放最大量为4.93±3.43纳克的白三烯B4(LTB4)和0.43±0.23纳克的白三烯C4(LTC4)(平均值±标准差,n = 3)。每毫升含50微克可溶性β-葡聚糖对单核细胞进行预孵育,可使随后单核细胞对每毫升5×10⁶个酵母聚糖颗粒和每毫升2.2×10⁶个葡聚糖颗粒的摄取分别减少52%和55%,并使每毫升含2×10⁸个酵母聚糖颗粒和每毫升8.6×10⁶个葡聚糖颗粒刺激的单核细胞释放LTB4分别减少73%和61%。每毫升含1毫克可溶性甘露聚糖预孵育对单核细胞对酵母聚糖或葡聚糖颗粒的吞噬作用或LTB4生成影响很小,可溶性β-葡聚糖和甘露聚糖均不刺激LTB4或LTC4的生成。可溶性β-葡聚糖对单核细胞预处理的作用具有时间依赖性,预处理20分钟内效果最为明显,且对酵母聚糖或葡聚糖颗粒具有特异性,因为2.5微摩尔钙离子载体A₂₃₁₈₇诱导的LTB4和LTC4释放不受影响。可溶性β-葡聚糖而非甘露聚糖以与单核细胞单层吞噬过程相符的速率抑制吞噬作用和白三烯生成,这表明存在针对β-葡聚糖受体的配体特异性。由于β-葡聚糖受体识别替代补体途径的颗粒状激活剂,对单一刺激的非免疫反应可诱导补体激活、吞噬作用和白三烯生成。